Evaluation of Naringenin as a Promising Treatment Option for COPD Based on Literature Review and Network Pharmacology

Biomolecules. 2020 Dec 8;10(12):1644. doi: 10.3390/biom10121644.

Abstract

Chronic obstructive pulmonary disease (COPD) is a chronic respiratory disease characterized by incompletely reversible airflow limitation and seriously threatens the health of humans due to its high morbidity and mortality. Naringenin, as a natural flavanone, has shown various potential pharmacological activities against multiple pathological stages of COPD, but available studies are scattered and unsystematic. Thus, we combined literature review with network pharmacology analysis to evaluate the potential therapeutic effects of naringenin on COPD and predict its underlying mechanisms, expecting to provide a promising tactic for clinical treatment of COPD.

Keywords: COPD; mechanism; naringenin; pathogenesis.

Publication types

  • Review

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / chemistry
  • Anti-Inflammatory Agents / therapeutic use*
  • Antioxidants / chemistry
  • Antioxidants / therapeutic use*
  • Cell Line
  • Expectorants / chemistry
  • Expectorants / therapeutic use*
  • Flavanones / chemistry
  • Flavanones / therapeutic use*
  • Gene Ontology
  • Humans
  • Lung / drug effects
  • Lung / immunology
  • Lung / pathology
  • Mice
  • Molecular Sequence Annotation
  • Molecular Targeted Therapy / methods
  • Pharmacogenetics / methods
  • Protein Interaction Mapping
  • Pulmonary Disease, Chronic Obstructive / drug therapy*
  • Pulmonary Disease, Chronic Obstructive / genetics
  • Pulmonary Disease, Chronic Obstructive / immunology
  • Pulmonary Disease, Chronic Obstructive / pathology
  • Respiratory System Agents / chemistry
  • Respiratory System Agents / therapeutic use*

Substances

  • Anti-Inflammatory Agents
  • Antioxidants
  • Expectorants
  • Flavanones
  • Respiratory System Agents
  • naringenin
  • naringin